Your session is about to expire
← Back to Search
Behavioral Intervention
Prolonged Exposure for Primary Care (PE-PC) for Post-Traumatic Stress Disorder (PE-PC Trial)
N/A
Waitlist Available
Led By Sheila A.M. Rauch, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Any era Veterans seeking care in VA PC for PTSD symptoms (PCL-5 28) and PTSD confirmed based on CAPS
English speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0, 6, 12, 24
Awards & highlights
PE-PC Trial Summary
This trial will study whether a brief therapy for PTSD is effective for Veterans who receive care in VHA Primary Care. The therapy may improve function in a short-term, brief protocol and provide an alternative point of access to effective PTSD treatment.
Eligible Conditions
- Post-Traumatic Stress Disorder
PE-PC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPE-PC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 0, 6, 12, 24
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0, 6, 12, 24
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
World Health Organization Disability Assessment Scale
World Health Organization Disability Assessment Scale Change
Secondary outcome measures
Clinician Administered PTSD Scale for DSM 5 (CAPS5
Clinician Administered PTSD Scale for DSM 5 (CAPS5)
Clinician Administered PTSD Scale for DSM 5 (CAPS5) Change
+4 morePE-PC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Prolonged Exposure for Primary Care (PE-PC)Experimental Treatment1 Intervention
Brief version of PE provided in 30 minute sessions in PC
Group II: Treatment as Usual (TAU)Active Control1 Intervention
Veterans assigned to PCMHI-TAU will receive standard PCMHI care for PTSD in PC that does not include any PTSD-specific therapy in PCMHI but may include referral for specialty care (including specialty MH), medication management or general supportive contact while awaiting referral. All PTSD care received during the study will be collected and monitored as TAU.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prolonged Exposure for Primary Care (PE-PC)
2019
N/A
~120
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,605 Previous Clinical Trials
3,305,476 Total Patients Enrolled
Ralph H. Johnson VA Medical CenterFED
18 Previous Clinical Trials
5,474 Total Patients Enrolled
VA Ann Arbor Healthcare SystemFED
17 Previous Clinical Trials
12,928 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger